Investor Rights Agreements in the Health Care Providers & Services Industry

61 Contracts & Agreements

Browse by Company

1Life Healthcare Inc (2 contracts)
ACELL INC (1)
BIODESIX INC (1)
BIOFORM MEDICAL INC (1)
BIOSPHERE MEDICAL INC (1)
CAPITAL SENIOR LIVING CORP (1)
Cardiva Medical, Inc. (1)
Deerfield Healthcare Technology Acquisitions Corp. (1)
Diplomat Pharmacy, Inc. (1)
Emphasys Medical, Inc. (2)
Encore Medical IHC, Inc. (1)
ENTELLUS MEDICAL INC (1)
EXAGEN INC. (3)
EXTEND HEALTH INC (1)
Fractyl Health, Inc. (1)
Fulgent Genetics, Inc. (1)
Guardant Health, Inc. (1)
HANSEN MEDICAL INC (4)
HUIHENG MEDICAL, INC. (4)
InfuSystem Holdings, Inc (1)
Interpace Diagnostics Group, Inc. (4)
Intuity Medical, Inc. (1)
Jaws Acquisition Corp. (1)
Mevion Medical Systems, Inc. (1)
MICROTEK MEDICAL HOLDINGS, INC (1)
Nalu Medical, Inc. (1)
NxStage Medical, Inc. (1)
Obagi Medical Products, Inc. (2)
Power Medical Interventions, Inc. (1)
Precipio, Inc. (1)
Progyny, Inc. (1)
PROJECT ROADRUNNER PARENT INC. (2)
R1 RCM INC. (6)
Restore Medical, Inc. (2)
SALT LAKE REGIONAL MEDICAL CENTER INC (1)
Sentio Healthcare Properties Inc (1)
SOLTA MEDICAL INC (1)
TRANSOMA MEDICAL INC (1)
Wellcare Health Plans, Inc (1)
ZONARE MEDICAL SYSTEMS INC (1)

Recent Contracts

Amended and Restated Investor Rights Agreement, dated as of October 10, 2024, by and among Interpace Biosciences, Inc., 1315 Capital II, L.P. and Ampersand 2018 Limited Partnership (Interpace Diagnostics Group, Inc., Filed With SEC on October 15, 2024)
Amendment No. 1 to Investor Rights Agreement, dated as of February 5, 2024, by and between R1 RCM Inc., CoyCo 1, L.P. and Coyco 2, L.P (PROJECT ROADRUNNER PARENT INC., Filed With SEC on February 6, 2024)
Amendment No. 1 to Amended and Restated Investor Rights Agreement, dated as of February 5, 2024, by and between R1 RCM Inc. and TCP-ASC ACHI Series LLLP (PROJECT ROADRUNNER PARENT INC., Filed With SEC on February 6, 2024)
Fifth Amended and Restated Investors Rights Agreement, dated June 9, 2021, by and among the Registrant and certain of its stockholders (Fractyl Health, Inc., Filed With SEC on December 14, 2023)
Investor Rights Agreement, dated as of November 10, 2022, by and between CareMax, Inc., Dr. Ralph de la Torre, Dr. Michael Callum, and certain other equityholders (Deerfield Healthcare Technology Acquisitions Corp., Filed With SEC on November 14, 2022)
Investor Rights Agreement, dated June 21, 2022, by and among the Company and the Sellers (R1 RCM INC., Filed With SEC on June 21, 2022)
Amended and Restated Investor Rights Agreement, dated June 21, 2022, by and among the Company, Old R1 RCM and TCP-ASC ACHI Series LLLP (R1 RCM INC., Filed With SEC on June 21, 2022)
Form of Investor Rights Agreement between Project Roadrunner Parent Inc., Coyco 1, L.P. and Coyco 2, L.P (R1 RCM INC., Filed With SEC on January 11, 2022)
Form of Amended and Restated Investor Rights Agreement between the Company, Project Roadrunner Parent Inc. and TCP-ASC ACHI Series LLLP (R1 RCM INC., Filed With SEC on January 11, 2022)
Form of Investor Rights Agreement by and between Interpace Biosciences, Inc. and 3K Limited Partnership, to be entered into at the closing of the Standby Purchase Commitment (Interpace Diagnostics Group, Inc., Filed With SEC on January 3, 2022)
Investor Rights Agreement, dated as of November 3, 2021, by and among Capital Senior Living Corporation, Conversant Dallas Parkway (A) LP, Conversant Dallas Parkway (B) LP and... (CAPITAL SENIOR LIVING CORP, Filed With SEC on November 4, 2021)
Eleventh Amended and Restated Investors Rights Agreement, dated October 15, 2020, by and among Intuity Medical, Inc. and the investors listed therein, as amended (Intuity Medical, Inc., Filed With SEC on September 17, 2021)
Amended and Restated Investor Rights Agreement among the Registrant and certain of its stockholders, dated July 3, 2020 (Nalu Medical, Inc., Filed With SEC on July 9, 2021)
Investor Agreement, dated as of June 3, 2021, by and among Cano Health, Inc., Primary Care (ITC) Holdings, LLC and the investors parties (Jaws Acquisition Corp., Filed With SEC on June 9, 2021)
Form of Amendment to Investor Rights Agreement between R1 RCM Inc. and TCP-ASC ACHI Series LLLP (R1 RCM INC., Filed With SEC on January 6, 2021)
Ninth Amended and Restated Investors Rights Agreement, dated June 29, 2020, by and among the Registrant and the investors listed on Exhibit A thereto (Cardiva Medical, Inc., Filed With SEC on January 4, 2021)
Eleventh Amended and Restated Investor Rights Agreement, by and among Biodesix, Inc. and the investors listed on Exhibit A thereto, dated October 10, 2018 (BIODESIX INC, Filed With SEC on October 2, 2020)
Second Amended and Restated Investor Rights Agreement, dated as of April 12, 2011 (ACELL INC, Filed With SEC on June 26, 2020)
Amended and Restated Investor Rights Agreement, dated January 15, 2020, by and among the Registrant and the investors listed on Exhibit A thereto (1Life Healthcare Inc, Filed With SEC on January 21, 2020)
Amended and Restated Investor Rights Agreement, dated as of January 15, 2020, by and among Interpace Biosciences, Inc., 1315 Capital II, L.P. and Ampersand 2018 Limited Partnership (Interpace Diagnostics Group, Inc., Filed With SEC on January 17, 2020)
Amended and Restated Investor Rights Agreement, dated August 21, 2018, by and among the Registrant and the investors listed on Exhibit A thereto (1Life Healthcare Inc, Filed With SEC on January 3, 2020)
Amended and Restated Investor Rights Agreement, dated as of March 4, 2015, by and among the Registrant and certain of its stockholders (Progyny, Inc., Filed With SEC on September 27, 2019)
Amended and Restated Investors Rights Agreement, dated July 12, 2019, by and among the Registrant and certain of its stockholders (EXAGEN INC., Filed With SEC on August 23, 2019)
Investor Rights Agreement, dated July 15, 2019, by and between Interpace Diagnostics Group, Inc. and Ampersand 2018 Limited Partnership (Interpace Diagnostics Group, Inc., Filed With SEC on July 19, 2019)
Amended and Restated Investors Rights Agreement, dated May 9, 2017, by and among the Registrant and the investors listed therein (Guardant Health, Inc., Filed With SEC on September 6, 2018)
INVESTORS’ RIGHTS AGREEMENT (Precipio, Inc., Filed With SEC on June 30, 2017)
FULGENT THERAPEUTICS LLC INVESTORS RIGHTS AGREEMENT Dated as of May 17, 2016 TABLE OF CONTENTS (Fulgent Genetics, Inc., Filed With SEC on September 2, 2016)
EXAGEN DIAGNOSTICS, INC. FIFTH AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (EXAGEN INC., Filed With SEC on February 17, 2016)
INVESTOR RIGHTS AGREEMENT (R1 RCM INC., Filed With SEC on December 8, 2015)
SECONDAMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (HANSEN MEDICAL INC, Filed With SEC on March 12, 2015)
FIFTH AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (ENTELLUS MEDICAL INC, Filed With SEC on January 28, 2015)
FIRST AMENDMENT TO INVESTOR RIGHTS AGREEMENT (Sentio Healthcare Properties Inc, Filed With SEC on December 30, 2014)
AMENDEDAND RESTATED INVESTOR RIGHTS AGREEMENT (HANSEN MEDICAL INC, Filed With SEC on November 6, 2014)
EXAGEN DIAGNOSTICS, INC. FOURTH AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (EXAGEN INC., Filed With SEC on September 19, 2014)
FOURTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Mevion Medical Systems, Inc., Filed With SEC on September 11, 2014)
DIPLOMAT PHARMACY, INC. FIRST AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Diplomat Pharmacy, Inc., Filed With SEC on July 3, 2014)
INVESTOR RIGHTS AGREEMENT (HANSEN MEDICAL INC, Filed With SEC on August 8, 2013)
INVESTOR RIGHTS AGREEMENT (HANSEN MEDICAL INC, Filed With SEC on July 31, 2013)
EXTEND HEALTH, INC. AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT February 27, 2009 TABLE OF CONTENTS (EXTEND HEALTH INC, Filed With SEC on January 6, 2012)
INFUSYSTEM HOLDINGS, INC. and Mellon Investor Services, LLC Rights Agent Rights Agreement Dated as of November 12, 2010 TABLE OF CONTENTS (InfuSystem Holdings, Inc, Filed With SEC on November 12, 2010)